Breaking News Instant updates and real-time market news.

CBS

CBS

$51.27

-0.63 (-1.21%)

04:55
03/15/18
03/15
04:55
03/15/18
04:55

CBS management to meet with Jefferies

Meeting to be held in New York on March 15 hosted by Jefferies.

  • 15

    Mar

CBS CBS
$51.27

-0.63 (-1.21%)

02/16/18
COWN
02/16/18
NO CHANGE
Target $69
COWN
Outperform
CBS best positioned company in media, says Cowen
Cowen analyst Doug Creutz noted CBS reported solid Q1 results with good growth guidance for 2018. The analyst believes CBS is the best-positioned company in media to deal with ongoing changes in the landscape due to its skew toward content and away from aggregation. Creutz reiterated his Outperform rating and $69 price target on CBS shares.
02/21/18
BMOC
02/21/18
NO CHANGE
Target $70
BMOC
Outperform
CBS price target lowered to $70 from $75 at BMO Capital
BMO Capital analyst Daniel Salmon lowers his price target on CBS (CBS) to $70 and kept his Outperform rating. Salmon says that while Q4 results showed a solid performance in affiliate fees and licensing deals, along with growth in direct-to-consumer offerings", the overhang from the potential Viacom (VIAB) deal continues to weigh on the stock. Longer term, the analyst believes that CBS remains uniquely positioned in media as it diversifies away from ad revenue to more recurring fee streams just as its content, licensing and syndication opportunities continue to grow.
02/28/18
02/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIA, VIAB) upgraded to Neutral from Underperform at Macquarie by analyst Tim Nollen, who told investors that the company has taken a decisive turn in strategy to re-set its distribution relationships and is in the early stages of a turnaround. Nollen believes Viacom can return to growth despite any merger outcome with CBS (CBS) and raised estimates on increased U.S. ad and affiliate revenue growth. 2. Tenet (THC) upgraded to Outperform from Market Perform at Raymond James by analyst John Ransom to reflect management's efforts to reduce costs and sell assets. Ransom said the company is reducing debt and could generate $400M in annual free cash flow until its NOL runs out. 3. AB InBev (BUD) upgraded to Positive from Neutral at Susquehanna by analyst Pablo Zuanic, who said the recent weakness provided an attractive entry point as the company had a great January to September period of organic growth, he sees deal synergies with SAB, and he believes Q4 was just as good if not better than the same period a year ago. 4. Etsy (ETSY) upgraded to Buy at Roth Capital by analyst Darren Aftahi after a "strong" Q4 and citing growth reacceleration and margin expansion. 5. Verizon (VZ) upgraded to Buy from Neutral at MoffettNathanson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/12/18
RBCM
03/12/18
NO CHANGE
RBCM
Netflix growth and pricing power persist, says RBC Capital
RBC Capital analyst Steven Cahall writes that Netflix is a "gold standard" in content value for consumer, resolving its subscriber issues that alarmed investors just over a year ago. Cahall contends that the company still has growth potential, with estimated 99M Pay TV U.S. household market vs. the company's current 55M U.S. subscriber count. The analyst also points to the "pricing power" of Netflix relative to the competition, stating that the U.S. user engagement of about 124 minutes per day is greater than any other standalone platform and amounts to about $0.003 per watched minute compared to Premium Networks like HBO, Showtime, and Starz are "500%-800% more expensive to watch on a per-minute basis". Moreover, Cahall believes the company is proving itself in the international markets category, where it generated its first positive annual contribution margin in 2017. The analyst estimates that Netflix could have up to $20 in EPS power in the next 5 years, with its stock price rising to as high as $600 per share under a 20-30-times PE valuation.

TODAY'S FREE FLY STORIES

KMX

CarMax

07:42
12/14/18
12/14
07:42
12/14/18
07:42
Recommendations
CarMax analyst commentary  »

Wedbush…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 21

    Dec

AMD

AMD

$19.86

-0.63 (-3.07%)

, NVDA

Nvidia

$148.88

-0.02 (-0.01%)

07:42
12/14/18
12/14
07:42
12/14/18
07:42
Recommendations
AMD, Nvidia analyst commentary  »

Mizuho cuts AMD target to…

AMD

AMD

$19.86

-0.63 (-3.07%)

NVDA

Nvidia

$148.88

-0.02 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 08

    Jan

  • 08

    Jan

SUP

Superior Industries

$5.94

-0.21 (-3.41%)

07:39
12/14/18
12/14
07:39
12/14/18
07:39
Hot Stocks
Superior Industries CEO Don Stebbins to retire »

Superior Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$170.93

1.84 (1.09%)

07:39
12/14/18
12/14
07:39
12/14/18
07:39
Periodicals
Notable Apple analyst cuts iPhone shipment estimate by 20%, CNBC says »

Demand for iPhones is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$34.90

2.765 (8.60%)

07:38
12/14/18
12/14
07:38
12/14/18
07:38
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$34.90

2.765 (8.60%)

07:36
12/14/18
12/14
07:36
12/14/18
07:36
Recommendations
Ciena analyst commentary  »

Ciena price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.39

-0.14 (-0.57%)

, C

Citi

$55.77

-0.22 (-0.39%)

07:35
12/14/18
12/14
07:35
12/14/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.39

-0.14 (-0.57%)

C

Citi

$55.77

-0.22 (-0.39%)

JD

JD.com

$22.71

0.81 (3.70%)

WFC

Wells Fargo

$47.03

-0.72 (-1.51%)

M

Macy's

$30.80

-1.0425 (-3.27%)

SBUX

Starbucks

$66.90

0.8 (1.21%)

CLF

Cleveland-Cliffs

$8.23

-0.135 (-1.61%)

MET

MetLife

$39.52

-0.05 (-0.13%)

NWL

Newell Brands

$22.78

-0.785 (-3.33%)

MRVL

Marvell

$15.64

0.29 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 06

    Jan

  • 08

    Jan

  • 14

    Jan

  • 15

    Jan

  • 12

    Feb

  • 12

    Apr

  • 15

    Apr

  • 18

    Jun

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

ICLR

Icon

$136.31

-1.83 (-1.32%)

07:34
12/14/18
12/14
07:34
12/14/18
07:34
Downgrade
Icon rating change  »

Icon downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.01

-0.29 (-1.90%)

07:33
12/14/18
12/14
07:33
12/14/18
07:33
Hot Stocks
Orchard Therapeutics, SIRION Biotech enter license agreement for LentiBOOST »

Orchard Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$16.33

-0.24 (-1.45%)

07:32
12/14/18
12/14
07:32
12/14/18
07:32
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GE

General Electric

$7.20

0.48 (7.14%)

, OSTK

Overstock.com

$17.97

-1.13 (-5.92%)

07:30
12/14/18
12/14
07:30
12/14/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$7.20

0.48 (7.14%)

OSTK

Overstock.com

$17.97

-1.13 (-5.92%)

GME

GameStop

$12.79

-0.445 (-3.36%)

ESRX

Express Scripts

$98.94

2.03 (2.09%)

CC

Chemours

$27.15

0.485 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
12/14/18
12/14
07:30
12/14/18
07:30
General news
Treasury Market Outlook: yields are dropped on risk-off flows »

Treasury Market Outlook:…

SEE

Sealed Air

$32.41

-1.05 (-3.14%)

07:29
12/14/18
12/14
07:29
12/14/18
07:29
Upgrade
Sealed Air rating change  »

Sealed Air upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$247.71

2.27 (0.92%)

07:27
12/14/18
12/14
07:27
12/14/18
07:27
Recommendations
Adobe analyst commentary  »

Adobe valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$226.41

-1.41 (-0.62%)

07:25
12/14/18
12/14
07:25
12/14/18
07:25
Recommendations
Costco analyst commentary  »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$137.58

-0.26 (-0.19%)

07:25
12/14/18
12/14
07:25
12/14/18
07:25
Conference/Events
Visa management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 29

    Jan

BECN

Beacon Roofing

$31.84

-0.22 (-0.69%)

07:24
12/14/18
12/14
07:24
12/14/18
07:24
Downgrade
Beacon Roofing rating change  »

Beacon Roofing downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$62.26

0.06 (0.10%)

07:24
12/14/18
12/14
07:24
12/14/18
07:24
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

DRGDF

Detour Gold

$0.00

(0.00%)

07:19
12/14/18
12/14
07:19
12/14/18
07:19
Downgrade
Detour Gold rating change  »

Detour Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$186.53

2.99 (1.63%)

, YUM

Yum! Brands

$93.49

3.02 (3.34%)

07:19
12/14/18
12/14
07:19
12/14/18
07:19
Recommendations
McDonald's, Yum! Brands analyst commentary  »

JPMorgan calls…

MCD

McDonald's

$186.53

2.99 (1.63%)

YUM

Yum! Brands

$93.49

3.02 (3.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNN

National Retail Properties

$50.86

0.94 (1.88%)

07:18
12/14/18
12/14
07:18
12/14/18
07:18
Downgrade
National Retail Properties rating change  »

National Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRGDF

Detour Gold

$0.00

(0.00%)

07:16
12/14/18
12/14
07:16
12/14/18
07:16
Downgrade
Detour Gold rating change  »

Detour Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLCM

Bellicum Pharmaceuticals

$3.60

-0.155 (-4.13%)

07:15
12/14/18
12/14
07:15
12/14/18
07:15
Hot Stocks
Bellicum Pharmaceuticals reports data from BPX-601 at ESMO-IO »

Bellicum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THG

Hanover Insurance

$109.52

-0.68 (-0.62%)

07:14
12/14/18
12/14
07:14
12/14/18
07:14
Conference/Events
Hanover Insurance management to meet with Buckingham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

BHC

Bausch Health

$23.65

-0.47 (-1.95%)

07:12
12/14/18
12/14
07:12
12/14/18
07:12
Upgrade
Bausch Health rating change  »

Bausch Health upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.